New York, NY & Mainz, DE…Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the submission of new data to the U.S. Food and Drug Administration (FDA) demonstrating the stability of their COVID-19 vaccine when stored at -25°C to -15°C (-13°F to 5°F), temperatures more commonly found in pharmaceutical freezers and refrigerators. The data have been submitted to the FDA to support a proposed update to the U.S. Emergency Use Authorization (EUA) Prescribing Information, which would allow for vaccine vials to be stored at these temperatures for a total of two weeks as an alternative or complement to storage in an ultra-low temperature freezer. The FDA submission includes stability da
Hence then, the article about pfizer and biontech submit covid 19 vaccine stability data at standard freezer temperature was published today ( ) and is available onThepintree.net ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature )